SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-10
👔
OptimizeRx Corp
@OPRX_InsiderForm 4 Filing: WASSON GREGORY D Acquires (Grant) shares of $OPRX
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
OptimizeRx Corp
Ticker: $OPRX
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-09
Shares: 34,517
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, WASSON GREGORY D, holds the title of Director at OptimizeRx Corp.
On 2026-06-09, the insider transacted 34,517 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
WASSON GREGORY D (Director) was granted $0 of $OPRX
Post-Transaction Position: 91,700 shares
SEC Accession No: 0001628280-26-042128 (CIK: 1188827)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.